N
|
57 |
53 |
|
18 |
26 |
|
Maternal age, years |
37.8 (2.9) |
37.5 (3.1) |
0.61 |
37.2 (2.5) |
37.3 (3.4) |
0.45 |
Paternal age, years |
39.5 (4.6) |
39.4 (5.1) |
0.96 |
39.4 (4.8) |
38.0 (4.8) |
0.51 |
Maternal race/ethnicity |
Caucasian |
53 (93.0%) |
53 (100%) |
0.12 |
13 (72.2%) |
22 (84.6%) |
0.45 |
Non-Hispanic |
55 (96.5%) |
52 (98.1%) |
1 |
14 (77.8%) |
21 (80.8%) |
1 |
Paternal race/ethnicity |
Caucasian |
54 (94.7%) |
50 (94.3%) |
1 |
15 (83.3%) |
22 (84.6%) |
1 |
Non-Hispanic |
56 (98.3%) |
51 (96.2%) |
0.61 |
15 (83.3%) |
21 (80.8%) |
1 |
Fetal race/ethnicity |
Caucasian |
53 (93.0%) |
50 (94.3%) |
1 |
12 (66.7%) |
20 (76.9%) |
0.51 |
Non-Hispanic |
55 (96.5%) |
51 (96.2%) |
1 |
13 (72.2%) |
20 (76.9%) |
0.74 |
Maternal pre-pregnancy BMI, kg/m2 |
22.0 (3.4) |
21.8 (3.4) |
0.54 |
23.9 (4.6) |
24.0 (4.8) |
0.98 |
Maternal preexisting medical conditions |
Hypertension |
0 (0%) |
0 (0%) |
- |
0 (0%) |
0 (0%) |
- |
Diabetes |
0 (0%) |
0 (0%) |
- |
0 (0%) |
0 (0%) |
- |
Pregnancy complications |
Hypertension |
0 (0%) |
0 (0%) |
- |
3 (16.7%) |
5 (19.2%) |
1 |
Diabetes |
1 (1.8%) |
2 (3.8%) |
0.42 |
0 (0%) |
1 (3.9%) |
1 |
Placenta previa |
0 (0%) |
0 (0%) |
- |
0 (0%) |
1 (3.9%) |
1 |
Placental abruption |
0 (0%) |
0 (0%) |
- |
0 (0%) |
0 (0%) |
- |
Hypertension management in pregnancy |
Anti-hypertensives |
0 (0%) |
0 (0%) |
- |
1 (5.6%) |
2 (7.7%) |
1 |
Any magnesium use (ante- or postpartum) |
0 (0%) |
0 (0%) |
- |
2 (11.1%) |
4 (15.4%) |
1 |
Mode of delivery- Cesarean section |
19 (33.3%) |
14 (26.4%) |
0.45 (chi2) |
7 (38.9%) |
8 (30.8%) |
0.59 (chi2) |
Gestational age at delivery, days |
276.2 (7.0) |
276.3 (7.0) |
0.95 |
278.8 (5.2) |
275.0 (9.3) |
0.13 |
Birthweight, g
|
3342.0 (430.1) |
3536.0 (481.3) |
0.03*, (ttest) |
3397.6 (409.5) |
3525.5 (504.1) |
0.48 |
(B) Comparison of sex-specific first and third trimester samples |
|
Female (N = 75) |
Male (N = 79) |
|
First |
Third |
P value |
First |
Third |
P value |
N |
57 |
18 |
|
53 |
26 |
|
Maternal age, years |
37.8 (2.9) |
37.2 (2.5) |
0.34 |
37.5 (3.1) |
37.3 (3.4) |
0.87 |
Paternal age, years |
39.5 (4.6) |
39.4 (4.8) |
0.79 |
39.4 (5.1) |
38.0 (4.8) |
0.27 |
Maternal race/ethnicity |
Caucasian |
53 (93.0%) |
13 (72.2%) |
0.03*
|
53 (100%) |
22 (84.6%) |
0.01*
|
Non-Hispanic |
55 (96.5%) |
14 (77.8%) |
0.03*
|
52 (98.1%) |
21 (80.8%) |
0.01*
|
Paternal race/ethnicity |
Caucasian |
54 (94.7%) |
15 (83.3%) |
0.15 |
50 (94.3%) |
22 (84.6%) |
0.21 |
Non-Hispanic |
56 (98.3%) |
15 (83.3%) |
0.04*
|
51 (96.2%) |
21 (80.8%) |
0.04*
|
Fetal race/ethnicity |
Caucasian |
53 (93.0%) |
12 (66.7%) |
0.01*
|
50 (94.3%) |
20 (76.9%) |
0.053 |
Non-Hispanic |
55 (96.5%) |
13 (72.2%) |
0.007*
|
2 (3.8%) |
6 (23.1%) |
0.014*
|
Maternal pre-pregnancy BMI, kg/m2
|
22.0 (3.4) |
23.9 (4.6) |
0.11 |
21.8 (3.4) |
24.0 (4.8) |
0.03*
|
Maternal preexisting medical conditions |
Hypertension |
0 (0%) |
0 (0%) |
- |
0 (0%) |
0 (0%) |
- |
Diabetes |
0 (0%) |
0 (0%) |
- |
0 (0%) |
0 (0%) |
- |
Thyroid disorder |
1 (1.8%) |
2 (11.1%) |
0.14 |
2 (3.8%) |
4 (15.4%) |
0.087 |
Pregnancy complications |
Hypertension |
0 (0%) |
3 (16.7%) |
0.012*
|
0 (0%) |
5 (19.2%) |
0.003*
|
Diabetes |
1 (1.8%) |
0 (0%) |
1 |
2 (3.8%) |
1 (3.9%) |
1 |
Placenta previa |
0 (0%) |
0 (0%) |
- |
0 (0%) |
1 (3.9%) |
0.55 |
Placental abruption |
0 (0%) |
0 (0%) |
- |
0 (0%) |
0 (0%) |
- |
Hypertension management in pregnancy |
Anti-hypertensives |
0 (0%) |
1 (5.6%) |
0.24 |
0 (0%) |
2 (7.7%) |
0.11 |
Any magnesium use (ante- or Postpartum) |
0 (0%) |
2 (11.1%) |
0.055 |
0 (0%) |
4 (15.4%) |
0.003*
|
Mode of delivery- Cesarean section |
19 (33.3%) |
7 (38.9%) |
0.67 (chi2) |
14 (26.4%) |
8 (30.8%) |
0.72 (chi2) |
Gestational age at delivery, days |
276.2 (7.0) |
278.8 (5.2) |
0.099 |
276.3 (7.0) |
275.0 (9.3) |
0.84 |
Birthweight, g |
3342.0 (430.1) |
3397.6 (409.5) |
0.77 |
3536.0 (481.3) |
3525.5 (504.1) |
0.93 |